Biomarkers such as Ki67, HSP60, Survivin, PD-L1, E-cadherin, Stathmin, and Cathepsin B have shown significant associations with tumor progression, metastasis, and poor prognosis, supported by the results from the studies analyzed. The gene discussed is CDH1; the disease is neoplasm.